Bialanx is a bioelectronics company that develops novel bioelectronic detection platforms.
Bialanx develops novel bioelectronic detection platforms that use integrated circuits for biochemical applications. Their technology leverages consumer CMOS technology to enable new avenues of real-time and label-free detection of proteins and nucleic acids.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 6, 2013 | Grant | $150K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |